Manufacturers Life Insurance Company, The Madrigal Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 22,945 shares of MDGL stock, worth $7.19 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,945
Previous 24,080
4.71%
Holding current value
$7.19 Million
Previous $7.43 Million
2.29%
% of portfolio
0.01%
Previous 0.01%
Shares
34 transactions
Others Institutions Holding MDGL
# of Institutions
366Shares Held
23.2MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$691 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$658 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$634 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$625 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$619 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.36B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...